Faeth Therapeutics, Inc. (FTH)
12.68
-9.37
(-42.49%)
USD |
NASDAQ |
Nov 09, 16:00
12.39
-0.29
(-2.29%)
After-Hours: 04:21
Faeth Therapeutics Debt to Equity Ratio : 0.0009 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0009 |
| June 30, 2026 | 0.0033 |
| March 31, 2026 | 0.0054 |
| December 31, 2025 | 0.0812 |
| September 30, 2025 | 0.0878 |
| June 30, 2025 | 0.0937 |
| March 31, 2025 | 0.1003 |
| December 31, 2024 | 0.1002 |
| September 30, 2024 | 0.0976 |
| June 30, 2024 | 0.0967 |
| March 31, 2024 | 0.0964 |
| December 31, 2023 | 0.0957 |
| September 30, 2023 | 0.0954 |
| June 30, 2023 | 0.0917 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.0817 |
| December 31, 2022 | 0.0777 |
| September 30, 2022 | 0.0737 |
| June 30, 2022 | 0.0689 |
| March 31, 2022 | 0.067 |
| December 31, 2021 | 0.0161 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.0035 |
| March 31, 2021 | 0.0033 |
| December 31, 2020 | 0.0357 |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -0.7603 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cypherpunk Technologies, Inc. | 0.0003 |
| Zymeworks, Inc. | 3.343 |
| Rhythm Pharmaceuticals, Inc. | 0.5268 |
| Cue Biopharma, Inc. | 3.813 |
| Yarrow Bioscience, Inc. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 178.95M |
| Total Liabilities (Quarterly) | 11.08M |
| Shareholders Equity (Quarterly) | 167.86M |
| Current Ratio | 16.12 |
| Net Debt Paydown Yield | 0.06% |